prompt1 : extract information from  breast pathology report. List the histological classification, i.e. type of cancer or DCIS, subtype, description of any necrosis, any mention of tumor infiltrating lymphocytes,  histological grade, nuclear grade,  lymphovascular invasion, calcification, receptor status, IHC and any other ancillary testing results.  List out and expand the main points.
prompt2 : The report is - Subtype LumA, Clinical Diagnosis & History: y/o female with 4.5 cm right breast mass biopsy positive for intraductal. carcinoma. Specimens Submitted: 1: SP: Sentinel node #1, level 1, right axilla (fs). 2: SP: Right breast and level 1, plus low level 2 axillary contents. 3: SP: Level 2 right axillary nodes. DIAGNOSIS: 1). SENTINEL NODE #1, LEVEL I, RIGHT AXILLA, BIOPSY: - ONE BENIGN LYMPH NODE (0/1). - ADDITIONAL H&E STAINED SECTIONS AND IMMUNOHISTOCHEMICAL STAINS FOR. CYTOKERATINS (AE1:AE3) SHOW NO EVIDENCE OF METASTATIC TUMOR. 2). BREAST, RIGHT LEVEL I AND LOW LEVEL II AXILLA CONTENTS, MODIFIED. RADICAL MASTECTOMY: - INVASIVE DUCTAL CARCINOMA, NOS TYPE, HISTOLOGIC GRADE III/III (SLIGHT. OR NO TUBULE FORMATION), NUCLEAR GRADE II/III (MODERATE VARIATION IN SIZE. AND SHAPE), MEASURING 5.0 CM IN LARGEST DIMENSION GROSSLY, SEE NOTE. - THE INVASIVE CARCINOMA IS LOCATED IN THE UPPER OUTER QUADRANT AND. LOWER OUTER QUADRANT. - NO INVOLVEMENT OF THE NIPPLE BY CARCINOMA IS IDENTIFIED. - NO DEFINITE EVIDENCE OF VASCULAR INVASION OF CARCINOMA IS NOTED. - THERE IS PERINEURAL INVASION OF CARCINOMA. - NO INVOLVEMENT OF THE SURGICAL MARGINS BY INVASIVE CARCINOMA IS. IDENTIFIED. - NO SKIN INVOLVEMENT BY CARCINOMA IS IDENTIFIED. - THE NON-NEOPLASTIC BREAST TISSUE SHOWS BIOPSY SITE CHANGES,. FIBROCYSTIC CHANGES WITH FLORID DUCTAL HYPERPLASIA AND FIBROADENOMA (1.6 CM). WITH COARSE MICROCALCIFICATIONS. ONE BENIGN INTRAPARENCHYMAL LYMPH NODE (0/1). - THE LYMPH NODE STATUS IS AS FOLLOWS (EXPRESSED AS THE NUMBER OF. POSITIVE LYMPH NODES IN RELATION TO THE TOTAL NUMBER OF LYMPH NODES. EXAMINED) : LEVEL I: 0/5. RECEPTOR IMMUNOHISTOCHEMISTRY DEMONSTRATES THE FOLLOWING STAINING PATTERNS. FOR THE INVASIVE CARCINOMA: ESTROGEN RECEPTOR (ER) POSITIVE, 95% NUCLEAR. STAINING WITH STRONG INTENSITY; PROGESTERONE RECEPTOR (PR) POSITIVE, 50%. NUCLEAR STAINING WITH MODERATE TO STRONG INTENSITY; AND HER2/NEU. Page 2 of. (HERCEPTEST) NEGATIVE, STAINING INTENSITY OF 0. CONTROLS ARE SATISFACTORY. NOTE: THE RESULTS OF OTHER IMMUNOHISTOCHEMISTRY STAINS SUPPORT THE ABOVR. DIAGNOSIS. SPECIFICALLY, THE TUMOR CELLS ARE POSITIVE FOR CITOKERATIN. 7, BRST-2, AND E-CADHERIN. WHEREAS THE TUMOR CELLS ARE NEGATIVE FOR CK20,. SMA, HHF35, SYNAPTOPHYSIN AND CHROMOGRANIN. 3). LYMPH NODES, LEVEL II, LEFT AXILLA, DISSECTION: FIVE BENIGN LYMPH NODES (0/5). I ATTEST THAT THE ABOVE DIAGNOSIS IS BASED UPON MY PERSONAL EXAMINATION OF. THE SLIDES (AND/OR OTHER MATERIAL), AND THAT I HAVE REVIEWED AND APPROVED. THIS REPORT. Special Studies: Special Stain. Comment. AE1:AE3. IMM RECUT. NEG CONT. ER-C. PR-C. CMA (HHF35). SMA. HER2-. CK7. CK20. BR2 (GCDFP). CHR. SYN. SYN. E-CADHERIN. IMM RECUT. NEG CONT. NEG-HER2. Gross Description: M.D. 1) The specimen is received fresh for frozen section consultation, labeled. "Sentinel node number one, level I, right axilla" and consists of two pink. tan fatty lymph nodes measuring 1 x 1 x 0.7 and 0.5 x 0.5 x 0.4 cm. The. largest lymph node is bisected, and the small lymph node is inked in blue. Entirely submitted for frozen section. Summary of sections: FSC -- frozen section control. M.D. rage. 2) The specimen is received fresh labeled, "Right breast and level I. and. low level II axillary contents" and consists of a breast with attached. axillary tail. The breast measures 28.5 x 26 x 4.0 cm with overlying skin. ellipse measuring 2.5 x 1.1 cm. Situated centrally on the skin surface is. an everted nipple measuring 1.2 x 1.1 x 0.4 cm and areola measuring 4 x 4. cm. The skin is grossly fixed and involved by a mass lesion measuring 5.0 x. 4.5 x 3.7cm situated in the upper and lower outer quadrants between 8 o'. clock to 10 o' clock A suture demarcates the axillary tail which measures. 8 x 7 x 1 cm. No tags are present. The posterior surface of the breast is. inked black and the specimen is serially sectioned to reveal the mass is. abutting the posterior margin. The remaining breast tissue shows fibrofatty. cut surface. The axillary tissue is dissected to reveal multiple lymph. nodes, ranging in size from 0.3 cm to 1.5 cm. Representative sections are. submitted, including all identified lymph nodes. Additionally the container. has an irregular skin ellipse and subcutaneous tissue measuring 9.5 x 8.5 x. 1.5 cm with overlying skin measuring 8.5 x 6 cm which is grossly. unremarkable. Serial sectioning reveals unremarkable fatty cut surface. Summary of sections: N nipple. NB - nipple base. S - skin scar. D - deep margin. T tumor. UIQ - upper inner quadrant. LIQ - lower inner quadrant. UOQ - upper outer quadrant. LOQ - lower outer quadrant. LN - single lymph nodes. BLN - bisected lymph nodes. M.D. 3) The specimen is received in formalin and is labeled "Level II right. axillary nodes". It consists of fragments of fibroadipose tissue measuring. 5.5 x 3.5 x 1.5cm without orientation. Multiple lymph nodes are identified,. ranging in size from 0.5 cm to 1.5 cm. All identified lymph nodes are. submitted. Summary of sections: LNS - whole lymph nodes. Summary of Sections: Part 1: SP: Sentinel node #1, level 1, right axilla (fs). Block. Sect. Site. PCs. 1. FSC. 1. Part 2: SP: Right breast and level 1, plus low level 2 axillary contents. Block. Sect. Site. PCs. 2. bln. 2. 1. d. 1. 2. liq. 2. 3. In. 3. 2. loq. 2. 1. n. 1. 1. nb. 1. the. 1. s. 1. 3. 3. 2. uig. 2. 2. uog. 2. Part 3: SP: Level 2 right axillary nodes. Block. Sect. Site. PCs. 2. Ins. 2. Procedures/Addenda: Addendum. Date Complete. MD. Addendum Diagnosis. 2). BREAST, RIGHT LEVEL I AND LOW LEVEL II AXILLA CONTENTS; MODIFIED. RADICAL MASTECTOMY. - THE ORIGINAL DIAGNOSIS ON THIS CASE REMAINS UNCHANGED. THIS ADDENDUM. SERVES TO CLARIFY THAT, ON REPRESENTATIVE SECTIONS, THE INVASIVE CARCINOMA. APPROACHES THE EPIDERMIS OF THE BREAST SKIN, BUT DOES NOT DIRECTLY INVOLVE. THE EPIDERMIS. Intraoperative Consultation: The diagnoses given in this section pertain only to the tissue sample. examined at the time of the intraoperative consultation. 1). FROZEN SECTION DIAGNOSIS: NEGATIVE LYMPH NODE. PERMANENT DIAGNOSIS: SAME. D.

expanded version (tokens=2351) : 
 Histological classification: Invasive ductal carcinoma, NOS type.
Subtype: Luminal A.
Necrosis: No mention of necrosis.
Tumor infiltrating lymphocytes: No mention of tumor infiltrating lymphocytes.
Histological grade: III/III (slight or no tubule formation).
Nuclear grade: II/III (moderate variation in size and shape)
Lymphovascular invasion: No definite evidence of vascular invasion of carcinoma is noted.
Calcification: Non-neoplastic breast tissue shows biopsy site changes, fibrocystic changes with florid ductal hyperplasia and fibroadenoma (1.6 cm) with coarse microcalcifications.
Receptor status: Estrogen receptor (ER) positive (95% nuclear staining with strong intensity), Progesterone receptor (PR) positive (50% nuclear staining with moderate to strong intensity) and HER2/NEU (HERCEPTEST) negative.
Ancillary testing results: The tumor cells are positive for cytokeratin 7, BRST-2, and E-cadherin and negative for CK20, SMA, HHF35, synaptophysin, and chromogranin.
The lymph node status is as follows: Level I: 0/5

Note: The original diagnosis on this case remains unchanged. This addendum serves to clarify that, on representative sections, the invasive carcinoma approaches the epidermis of the breast skin but does not directly

prompt : Please generate a succinct report in 75 words from the above information. Exclude any filler words or sentences. If something is not mentioned or specified, exclude it from the report. Low verbosity.

final output (tokens=2546) : 
 Invasive ductal carcinoma, NOS type of luminal A subtype with a histological grade of III/III (slight or no tubule formation) and nuclear grade of II/III (moderate variation in size and shape) was found. No necrosis, tumor infiltrating lymphocytes, skin involvement or vascular invasion was identified. Lymph node status: Level I - 0/5. Receptor status shows ER and PR positive (strong intensity) and HER2/NEU negative. The tumor is positive for cytokeratin 7, BRST-2, and E-cadherin and negative for CK20, SMA, HHF35, synaptophysin, and chromogranin.

